Ligand Pharmaceuticals OverviewLigand Pharmaceuticals Net Income
Profitability analysis for LGND.
Quarterly Net Income
-$13.35M
↑ 68.56% YoY
As of Mar 2026
Annual Net Income (TTM)
$140.81M
↑ 206.17% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...